Results 211 to 220 of about 55,676 (335)
Development of a Formulation and In Vitro Evaluation of a Pulmonary Drug Delivery System for a Novel Janus Kinase (JAK) Inhibitor, CPL409116 [PDF]
Aleksandra Rzewińska +8 more
openalex +1 more source
The Journal of Dermatology, EarlyView.ABSTRACT Atopic dermatitis (AD) is a chronic inflammatory disease characterized by recurrent remissions and relapses. Topical anti‐inflammatory steroids are commonly used for treatment, but their long‐term use poses concerns because of potential side effects. Delgocitinib ointment, a Janus kinase inhibitor, has demonstrated efficacy in several clinical
Masatoshi Abe +5 more
wiley +1 more source
Biological Evaluations and Computer-Aided Approaches of Janus Kinases 2 and 3 Inhibitors for Cancer Treatment: A Review. [PDF]
PharmaceuticsVázquez-Jiménez LK +7 more
europepmc +1 more source
Janus kinases to jakinibs: from basic insights to clinical practice. [PDF]
Rheumatology (Oxford), 2019 Gadina M +6 more
europepmc +1 more source
FDA-approved small-molecule kinase inhibitors [PDF]
, 2015 Clausen, Mads Hartvig +2 more
core +1 more source
OP0032 Malignancies and serious infections in randomised controlled trials of janus kinase inhibitors in patients with rheumatoid arthritis: a systematic review and meta-analysis [PDF]
, 2018 María A. López-Olivo +4 more
openalex +1 more source
Pathogenesis of Vitiligo: Integrating Immune and Non‐Immune Cell Crosstalk
The Journal of Dermatology, EarlyView.ABSTRACT Vitiligo is an acquired autoimmune disease characterized by depigmented macules resulting from melanocyte loss. It is a complex multifactorial disorder in which genetic predisposition is combined with environmental factors; however, its detailed etiology remains unclear.
Shintaro Inoue
wiley +1 more source